Fact Sheet for Healthcare Providers: ExProbe SARS-CoV-2 Testing Kit – TBG Biotechnology Corp. | NLM

Disaster Information Management Research Center | NLM

Fact Sheet for Healthcare Providers: ExProbe SARS-CoV-2 Testing Kit – TBG Biotechnology Corp.

06/10/2020 12:00 AM EDT

Source: U.S. Food and Drug Administration (FDA). Published: 6/10/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the ExProbe SARS-CoV-2 Testing Kit. The ExProbe SARS-CoV-2 Testing Kit is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)